Patents by Inventor Olga Bandman

Olga Bandman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein-transport-associated molecules
    Publication number: 20050130204
    Abstract: The invention provides human protein transport molecules (PTAM) and polynucleotides which identify and encode PTAM. The Invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PTAM.
    Type: Application
    Filed: November 15, 2004
    Publication date: June 16, 2005
    Inventors: Y. Tang, Preeti Lal, Olga Bandman, Henry Yue, Neil Corley, Karl Guegler, Gina Gorgone, Mariah Baughn, Chandra Patterson
  • Membrane associated proteins
    Publication number: 20050123990
    Abstract: The invention provides human membrane associated proteins (MEMAP) and polynucleotides which identify and encode MEMAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of MEMAP.
    Type: Application
    Filed: February 2, 2005
    Publication date: June 9, 2005
    Inventors: Preeti Lal, Henry Yue, Y. Tang, Olga Bandman, Neil Burford, Yalda Azimzai, Mariah Baughn, Dyung Lu, Chandra Arivzu-Patterson
  • Proteases
    Publication number: 20050112565
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 26, 2005
    Inventors: Henry Yue, Dyung Lu, Jennifer Policky, Angelo Delegeane, Catherine Tribouley, Farrah Khan, Janice Au-Young, Olga Bandman, Preeti Lal, Mark Borowsky, Ameena Gandhi, Jennifer Hillman, Y. Tang, Neil Burford, Mariah Baughn, Danniel Nguyen, Monique Yao, Narinder Walia, Ann He, April Hafalia, Yan Lu, Chandra Arvizu
  • Human regulatory proteins
    Publication number: 20050084936
    Abstract: The invention provides human regulatory proteins collectively designated HRGP, and polynucleotides which identify and encode these molecules. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing, treating, and preventing disorders associated with expression of human regulatory proteins.
    Type: Application
    Filed: October 18, 2004
    Publication date: April 21, 2005
    Inventors: Preeti Lal, Olga Bandman, Jennifer Hillman, Janice Au-Young, Y. Tang, Henry Yue, Purvi Shah, Karl Guegler, Neil Corley
  • Human receptor molecules
    Publication number: 20050079575
    Abstract: The invention provides human receptor molecules (REC) and polynucleotides which identify and encode REC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of REC.
    Type: Application
    Filed: June 21, 2004
    Publication date: April 14, 2005
    Inventors: Jennifer Hillman, Olga Bandman, Y. Tang, Henry Yue, Preeti Lal, Neil Corley, Karl Guegler, Chandra Patterson
  • Oxidoreductase molecules
    Publication number: 20050053987
    Abstract: The invention provides human oxidoreductase molecules (OXRE) and polynucleotides which identify and encode OXRE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of OXRE.
    Type: Application
    Filed: July 20, 2004
    Publication date: March 10, 2005
    Inventors: Preeti Lal, Karl Guegler, Gina Gorgone, Neil Corley, Mariah Baughn, Y. Tang, Jennifer Hillman, Olga Bandman, Yalda Azimzai, Janice Au-Young, Henry Yue, Dyung Lu, Junming Yang
  • Human transport proteins
    Publication number: 20050048610
    Abstract: This invention relates to nucleic acid and amino acid sequences of human transport proteins and to the use of these sequences in the diagnosis, treatment, and prevention of transport, metabolic, neurological, cardiovascular, reproductive, and immune disorders, and cell proliferative disorders including cancer.
    Type: Application
    Filed: June 24, 2004
    Publication date: March 3, 2005
    Inventors: Preeti Lal, Junming Yang, Henry Yue, Jennifer Jackson, Y. Tang, Olga Bandman, Neil Burford, Mariah Baughn, Yalda Azimzai, Dyung Lu, Janice Au-Young, Chandra Arvizu
  • Cell cycle and proliferation proteins
    Publication number: 20050048623
    Abstract: The invention provides human cell cycle and proliferation proteins (CCYPR) and polynucleotides which identify and encode CCYPR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CCYPR.
    Type: Application
    Filed: October 6, 2004
    Publication date: March 3, 2005
    Inventors: Jennifer Hillman, Preeti Lal, Y. Tang, Henry Yue, Janice Au-Young, Olga Bandman, Yalda Azimzai, Junming Yang, Dyung Lu, Mariah Baughn, Chandra Arvizu, Purvi Shah
  • Novel human sodium-dependent phosphate cotransporter
    Publication number: 20050042724
    Abstract: The present invention provides a human sodium-dependent phosphate cotransporter (NAPTR) and polynucleotides which identify and encode NAPTR. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NAPTR and a method for producing NAPTR. The invention also provides for agonists, antibodies, or antagonists specifically for NAPTR. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NAPTR for the treatment of diseases associated with the expression of NAPTR. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NAPTR. The invention also provides a method for treating disorders associated with decreased phosphate levels by administering NAPTR and a method for treating disorders associated with increased phosphate levels by administering antagonists to NAPTR.
    Type: Application
    Filed: June 25, 2004
    Publication date: February 24, 2005
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Olga Bandman
  • Receptors and associated proteins
    Publication number: 20050037466
    Abstract: The invention provides human receptors and associated proteins (RECAP) and polynucleotides which identify and encode RECAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of RECAP.
    Type: Application
    Filed: September 8, 2004
    Publication date: February 17, 2005
    Inventors: Janice Au-Young, Olga Bandman, Y. Tang, Henry Yue, Yalda Azimzai, Neil Burford, Mariah Baughn, Dyung Lu, Jennifer Hillman, Chandra Arvizu, Preeti Lal
  • Human protease molecules
    Patent number: 6855811
    Abstract: The invention provides human protease molecules (HUPM) and polynucleotides which identify and encode HUPM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HUPM.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: February 15, 2005
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Henry Yue, Karl J. Guegler, Neil C. Corley, Y. Tom Tang, Purvi Shah
  • Receptors and membrane-associated proteins
    Publication number: 20050033018
    Abstract: The invention provides human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
    Type: Application
    Filed: May 16, 2002
    Publication date: February 10, 2005
    Inventors: Preeti Lal, Bridget Warren, Yuming Xu, Brendan Duggan, Cynthia Honchell, Deborah Kallick, Mariah Baughn, Y. Tang, Henry Yue, Olga Bandman, Karen Jones, Shanya Becha, Uyen Tran, Janice Au-Young, Jennifer Griffin, Yeganeh Zebarjadian, Ernestie Lee, Vicki Elliott, Kavitha Thangavelu, Jayalaxmi Ramkumar, Yan Lu, April Hafalia, Narinder Chawla, Craig Ison, Michael Thornton, Anita Swarnakar, Junming Yang, Thomas Richardson, Brooke Emerling, Monique Yao, Benjamin Cocks, Bharati Sanjanwala, Patricia Mason, Ameena Gandhi, Joana Li, Rajagopal Gururajan, Kimberly Gietzen, Ian Forsythe
  • Novel human mage-like protein
    Publication number: 20050019304
    Abstract: The present invention provides a human MAGE-like protein (MAGELP) and polynucleotides which identify and encode MAGELP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding MAGELP and a method for producing MAGELP. The invention also provides for agonists, antibodies, or antagonists specifically binding MAGELP, and their use, in the prevention and treatment of diseases associated with expression of MAGELP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding MAGELP for the treatment of diseases associated with the expression of MAGELP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding MAGELP.
    Type: Application
    Filed: September 9, 2003
    Publication date: January 27, 2005
    Applicant: Incyte Corporation
    Inventors: Olga Bandman, Surya Goli
  • Human cytoskeleton associated proteins
    Publication number: 20050003447
    Abstract: The invention provides human cytoskeleton associated proteins (CYSKP) and polynucleotides which identify and encode CYSKP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CYSKP.
    Type: Application
    Filed: August 19, 2004
    Publication date: January 6, 2005
    Inventors: Preeti Lal, Y. Tang, Henry Yue, Jennifer Jackson, Olga Bandman, Neil Corley, Karl Guegler, Chandra Arvizu, Yalda Azimzai, Mariah Baughn
  • Protein transport-associated molecules
    Patent number: 6838241
    Abstract: The invention provides human protein transport molecules (PTAM) and polynucleotides which identify and encode PTAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of PTAM.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: January 4, 2005
    Assignee: Incyte Corporation
    Inventors: Y. Tom Tang, Preeti Lal, Olga Bandman, Henry Yue, Neil C. Corley, Karl J. Guegler, Gina A. Gorgone, Mariah R. Baughn, Chandra Patterson
  • Molecules for disease detection and treatment
    Publication number: 20040249128
    Abstract: Various embodiments of the invention provide human molecules for disease detection and treatment (MDDT) and polynucleotides which identify and encode MDDT. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of MDDT.
    Type: Application
    Filed: July 19, 2004
    Publication date: December 9, 2004
    Inventors: Michael B Thornton, Janice K Au-Young, Yalda Azimzai, Olga Bandman, Ines Barroso, Mariah R Baughn, Shanya D Becha, Mark L Borowsky, Li Ding, Brendan M Duggan, Vicki S Elliott, Brooke M Emerling, Ian J Forsythe, Ameena R Gandhi, Kimberly J Gietzen, Ann E Gorvad, Jennifer A Griffin, Rajagopal Gururajan, April J A Hafalia, Huijun Z Ring, Craig H Ison, Karen Anne Jones, Preeti G Lal, Ernestine A Lee, Sally Lee, Joana X Li, Dyung Aina M Lu, Joseph P. Marquis, Patricia M. Lehr-Mason, Narinder K. Chawla, Chandra S. Arvizu, Bharati Sanjanwala, Thierry R. Sornasse, Anita Swarnakar, Y Tom Tang, Kavitha Thangavelu, Bao Tran, Uyen K. Tran, Bridget A. Warren, Yuming Xu, Monique G. Yao, Henry Yue, Huibin Yue, Yeganeh Zebarjadian, Hsin-Ru Chang
  • Intracellular signaling molecules
    Publication number: 20040249127
    Abstract: Various embodiments of the invention provide human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INTSIG.
    Type: Application
    Filed: January 12, 2004
    Publication date: December 9, 2004
    Inventors: Olga Bandman, Mariah R. Baughn, Shanya D. Becha, Anna M. Chinn, Benjamin G. Cocks, Li Ding, Ian J. Forsythe, Kimberly J. Gietzen, Jennifer A. Griffin, April J. A. Hafalia, Farrah A. Khan, Preeti G. Lal, Ernestine A. Lee, Joana X. Li, Dyung Aina M. Lu, Jayalaxmi Ramkumar, Thomas W. Richardson, Anita Swarnakar, Y Tom Tang, Narinder K. Chawla, Bridget A. Warren, Junming Yang, Monique G. Yao, Henry Yue, Yeganeh Zebarjadian
  • DNA encoding oxidoreductase and polypeptide encoded thereby
    Patent number: 6808895
    Abstract: The invention provides human oxidoreductase molecules (OXRE) and polynucleotides which identify and encode OXRE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of OXRE.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: October 26, 2004
    Assignee: Incyte Corporation
    Inventors: Preeti Lal, Karl J. Guegler, Gina A. Gorgone, Neil C. Corley, Mariah R. Baughn, Y. Tom Tang, Jennifer L. Hillman, Olga Bandman, Yalda Azimzai, Janice Au-Young, Henry Yue, Dyung Aina M. Lu, Junming Yang
  • Human regulatory proteins
    Publication number: 20040203109
    Abstract: The invention provides human regulatory proteins and polynucleotides (collectively designated NHRP) which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human regulatory proteins.
    Type: Application
    Filed: May 10, 2004
    Publication date: October 14, 2004
    Applicant: Incyte Corporation
    Inventors: Preeti Lal, Olga Bandman, Jennifer L. Hillman, Purvi Shah, Neil C. Corley
  • Isomerases proteins
    Publication number: 20040185529
    Abstract: The invention provides human isomerases (ISOM) and polynucleotides which identify and encode ISOM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of ISOM.
    Type: Application
    Filed: December 5, 2003
    Publication date: September 23, 2004
    Applicant: Incyte Corporation
    Inventors: Olga Bandman, Dyung Aina M. Lu, Henry Yue, Bao Tran, Jennifer L. Hillman, Mariah R. Baughn, Preeti Lal, Y. Tom Tang